13 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00765 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | A549 | Human lung cancer | IC50 : 119.84 ± 16.01 μM |
| dbacp00766 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | Colo320 | Colon cancer | IC50 : 83.10 ± 1.41 μM |
| dbacp00767 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | HepG2 | Human hepatocarcinoma | IC50 : 107.34 ± 11.87 μM |
| dbacp00768 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | SW620 | Colon cancer | IC50 : 102.35 ± 4.66 μM |
| dbacp00769 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | HT-29 | Colorectal adenocarcinoma | IC50 : 96.00 ± 9.06 μM |
| dbacp00770 | A specific Eps8/EGFR Inhibitor Peptide 327 | EFLDCFQKF | A specific Eps8/EGFR Inhibitor Peptide 327 | Immune response to tumor cell recognition | Lactate dehydrogenase (LDH)-release assay | PC-3 | Pancreatic cancer | IC50 : 83.44 ± 4.62 μM |
| dbacp02293 | Carcinoembryonic antigen glypican-3 GPC3(144-152) | FVGEFFTDV | Carcinoembryonic antigen glypican-3 GPC3(144-152) | Immune response to tumor cell recognition | Cytotoxicity assay | HepG2 | Not specified | Not found |
| dbacp02294 | Carcinoembryonic antigen glypican-3 GPC3(144-152) | FVGEFFTDV | Carcinoembryonic antigen glypican-3 GPC3(144-152) | Immune response to tumor cell recognition | Cytotoxicity assay | G-401 | Wilm's tumor | Not found |
| dbacp02295 | Carcinoembryonic antigen glypican-3 GPC3(144-152) | FVGEFFTDV | Carcinoembryonic antigen glypican-3 GPC3(144-152) | Immune response to tumor cell recognition | Cytotoxicity assay | SK-N-DZ | Wilm's tumor | Not found |
| dbacp02296 | Carcinoembryonic antigen glypican-3 GPC3(144-152) | FVGEFFTDV | Carcinoembryonic antigen glypican-3 GPC3(144-152) | Immune response to tumor cell recognition | Cytotoxicity assay | HuH-6 | Wilm's tumor | Not found |
| dbacp02297 | Carcinoembryonic antigen glypican-3 GPC3(298-306) | EYILSLEEL | Carcinoembryonic antigen glypican-3 GPC3(298-306) | Immune response to tumor cell recognition | Cytotoxicity assay | MDA-MB-231 | Not specified | Not found |
| dbacp02298 | Carcinoembryonic antigen glypican-3 GPC3(298-306) | EYILSLEEL | Carcinoembryonic antigen glypican-3 GPC3(298-306) | Immune response to tumor cell recognition | Cytotoxicity assay | MCF-7 | Not specified | Not found |
| dbacp03328 | HSP70 peptide | ACFAEKFKEAVKDYFAKFWD-GSG-TKDNNLLGRFELSG | Not found | Immune response to tumor cell recognition | Cytotoxic assay, Lactate dehydrogenase (LDH) release assay | B16OVA | Necroptotic cancer | Not found |